MTAP-deleted Solid Tumors
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
2028
2029
2030
2031
BayerBAY 3713372
Tango TherapeuticsS095035
Clinical Trials (2)
Total enrollment: 712 patients across 2 trials
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors
Start: Mar 2025Est. completion: Jun 2029370 patients
Phase 1/2Recruiting
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Start: Apr 2024Est. completion: Oct 2031342 patients
Phase 1/2Recruiting
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Senior Director of Clinical Operations
Arvinas
Remote
1h ago
Specialist, Quality Assurance
Umoja Biopharma
Louisville, Colorado, United States
3h ago
$85K - $105K/yr
Senior Facilities Technician
Umoja Biopharma
Louisville, Colorado, United States
3h ago
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
7h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 712 patients
2 companies competing in this space